QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
NASDAQ:EPZM

Epizyme Insider Trades

$3.12
-0.01 (-0.32%)
(As of 12/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.06
$3.30
50-Day Range
$2.93
$5.43
52-Week Range
$2.83
$13.30
Volume
1.40 million shs
Average Volume
1.09 million shs
Market Capitalization
$324.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.06

Epizyme (NASDAQ:EPZM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
17.50%

Number Of
Insiders Buying
(Last 12 Months)
1

Amount Of
Insider Buying
(Last 12 Months)
$225.28 K

Number Of
Insiders Selling
(Last 12 Months)
6

Amount Of
Insider Selling
(Last 12 Months)
$272.08 K

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get EPZM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Epizyme stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Epizyme (NASDAQ EPZM) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/6/2021Shefali AgarwalInsiderSell1,780$2.93$5,215.40  
4/5/2021Jeffery KutokInsiderSell2,029$8.80$17,855.2054,028  
3/25/2021David M MottDirectorBuy28,231$7.98$225,283.38116,414  
3/25/2021Robert B. BazemoreCEOSell10,328$7.85$81,074.80  
2/4/2021Paolo TombesiCFOSell1,021$11.21$11,445.4153,465  
2/4/2021Robert B BazemoreCEOSell3,890$11.21$43,606.90331,977  
2/4/2021Shefali AgarwalInsiderSell969$11.21$10,862.49104,341  
1/25/2021Matthew RosInsiderSell2,872$11.41$32,769.52  
1/25/2021Robert B. BazemoreCEOSell6,069$11.41$69,247.29  
12/3/2020Shefali AgarwalInsiderSell2,522$13.54$34,147.8876,089  
11/11/2020Carl GoldfischerDirectorBuy5,000$12.07$60,350.005,000  
9/3/2020Joseph BeaulieuInsiderSell971$12.77$12,399.67  
6/26/2020David M MottDirectorBuy62,019$16.03$994,164.5782,601  
6/26/2020Joseph BeaulieuInsiderSell317$16.15$5,119.555,155  
6/26/2020Paolo TombesiCFOSell1,805$16.15$29,150.7523,747  
6/26/2020Robert B BazemoreCEOSell4,773$16.15$77,083.95254,871  
6/18/2020Matthew RosInsiderSell112,003$21.24$2,378,943.7292,861  
6/18/2020Robert B BazemoreCEOSell20,000$22.00$440,000.00264,371  
3/25/2020Joseph BeaulieuInsiderSell212$15.28$3,239.365,173  
3/25/2020Paolo TombesiCFOSell1,243$15.28$18,993.0416,680  
3/25/2020Robert B BazemoreCEOSell3,285$15.28$50,194.8080,726  
3/3/2020Joseph BeaulieuInsiderSell996$22.18$22,091.28  
1/27/2020Robert B BazemoreCEOSell6,074$20.44$124,152.5693,744  
1/27/2020Shefali AgarwalInsiderSell2,630$20.44$53,757.2063,276  
1/24/2020Robert B BazemoreCEOSell3,002$24.62$73,909.2493,744  
1/24/2020Shefali AgarwalInsiderSell1,843$24.64$45,411.5263,276  
6/26/2019David M MottDirectorSell104,944$13.08$1,372,667.5213,979  
6/13/2019Matthew RosInsiderSell1,185$12.10$14,338.5040,217  
6/13/2019Robert B BazemoreCEOSell2,074$12.10$25,095.4087,068  
10/5/2018David M MottDirectorBuy416,667$9.00$3,750,003.0012,088  
2/5/2018Matthew RosCOOSell72,264$16.63$1,201,750.3274,867  
10/24/2017Peter Tai-Ching HoInsiderSell15,000$16.44$246,600.0023,123  
9/25/2017Peter Tai-Ching HoInsiderSell15,000$16.81$252,150.0023,123  
9/18/2017David M MottDirectorBuy200,000$15.25$3,050,000.006,000  
8/24/2017Peter Tai-Ching HoInsiderSell15,000$15.68$235,200.0022,228  
7/24/2017Peter Tai-Ching HoInsiderSell15,000$13.44$201,600.0022,228  
6/30/2017Andrew E SingerCFOSell3,024$15.50$46,872.0040,529  
6/26/2017Peter Tai-Ching HoInsiderSell15,000$14.87$223,050.0022,228  
6/6/2017Robert A CopelandInsiderSell2,500$13.45$33,625.0034,038  
5/25/2017Peter Tai-Ching HoInsiderSell15,000$16.11$241,650.0022,228  
5/2/2017Robert A CopelandInsiderSell5,000$17.44$87,200.0036,538  
4/4/2017Robert A CopelandInsiderSell5,000$16.36$81,800.0033,538  
3/31/2017Andrew E SingerCFOSell2,013$17.09$34,402.1736,175  
1/9/2017Andrew E SingerCFOSell1,013$12.04$12,196.5233,506  
12/9/2016Andrew E SingerCFOSell1,013$11.03$11,173.3932,060  
11/9/2016Andrew E SingerCFOSell1,013$10.40$10,535.2030,613  
10/10/2016Andrew E SingerCFOSell1,013$9.72$9,846.3629,167  
9/9/2016Andrew E SingerCFOSell1,013$7.55$7,648.1527,721  
8/9/2016Andrew E SingerCFOSell1,013$9.05$9,167.6526,274  
8/1/2016Robert A CopelandInsiderSell4,000$10.37$41,480.0035,538  
7/11/2016Andrew E SingerCFOSell1,013$10.36$10,494.6824,828  
7/5/2016Robert A CopelandInsiderSell4,000$10.03$40,120.004,000  
6/9/2016Andrew E SingerCFOSell1,013$12.49$12,652.3723,382  
4/12/2016Andrew E SingerCFOSell1,013$12.42$12,581.4620,489  
3/9/2016Andrew E SingerCFOSell1,006$9.33$9,385.9819,036  
2/29/2016Peter Tai-Ching HoInsiderBuy636$7.47$4,750.92  
2/10/2016Andrew E. SingerCFOSell12,158$9.54$115,987.3217,354  
1/12/2016Bay City Capital Fund V Co-InvMajor ShareholderBuy555,555$9.00$4,999,995.00  
1/12/2016David M MottDirectorBuy1,111,111$9.00$9,999,999.00  
1/4/2016Robert A. CopelandinsiderSell4,185$15.58$65,202.30  
12/30/2015Robert J. GouldDirectorSell32,108$18.01$578,265.08  
12/9/2015Peter Tai-Ching HoInsiderBuy1,000$14.69$14,690.00  
12/7/2015Robert A. CopelandinsiderSell4,185$13.82$57,836.70  
11/9/2015Robert A. CopelandinsiderSell4,185$16.26$68,048.10  
10/5/2015Robert A. CopelandinsiderSell4,185$14.43$60,389.55  
9/8/2015Robert A. CopelandinsiderSell4,185$19.58$81,942.30  
9/8/2015Robert J. GouldCEOSell60,000$19.86$1,191,600.00  
7/6/2015Robert A CopelandInsiderSell8,371$22.86$191,361.06  
7/6/2015Robert J GouldCEOSell60,000$23.22$1,393,200.00  
5/5/2015Peter Tai-Ching HoInsiderBuy800$16.36$13,088.00  
12/2/2014Peter Tai-Ching HoInsiderBuy1,000$21.17$21,170.00  
11/17/2014Robert A CopelandEVPSell20,000$22.68$453,600.00  
11/3/2014Robert A CopelandEVPSell20,000$25.47$509,400.00  
11/3/2014Robert J GouldCEOSell30,000$24.95$748,500.00  
10/7/2014Robert A CopelandEVPSell20,000$26.90$538,000.00  
10/1/2014Robert J GouldCEOSell30,000$26.28$788,400.00  
10/1/2014Stephen GarbaczInsiderSell868$27.06$23,488.08  
9/22/2014Robert A CopelandEVPSell20,000$25.55$511,000.00  
9/15/2014Eric HedrickInsiderSell2,000$28.67$57,340.00  
9/4/2014Carl GoldfischerDirectorSell4,000$35.14$140,560.00  
8/26/2014Bay City Capital LlcMajor ShareholderSell200,000$35.14$7,028,000.00  
8/25/2014Bay City Capital LlcMajor ShareholderSell366,666$33.98$12,459,310.68  
8/18/2014Robert A CopelandEVPSell10,830$36.07$390,638.10  
8/15/2014Ryan D DrantMajor ShareholderSell4,061$36.54$148,388.94  
8/4/2014Jason P RhodesCFOSell30,000$29.74$892,200.00  
8/4/2014Robert A CopelandEVPSell20,000$29.42$588,400.00  
7/15/2014Eric HedrickInsiderSell2,000$31.35$62,700.00  
7/7/2014Jason P RhodesCFOSell30,000$32.74$982,200.00  
7/1/2014Robert J GouldCEOSell30,000$31.53$945,900.00  
6/23/2014Robert A CopelandEVPSell20,000$28.42$568,400.00  
6/16/2014Eric HedrickInsiderSell2,000$26.42$52,840.00  
6/16/2014Robert A CopelandEVPSell25,012$26.38$659,816.56  
6/2/2014Robert J GouldCEOSell30,000$22.20$666,000.00  
5/19/2014Robert CopelandEVPSell5,000$22.28$111,400.0017,561  
5/5/2014Jason RhodesCFOSell30,000$21.53$645,900.0046,000  
5/5/2014Robert CopelandEVPSell10,000$21.29$212,900.0020,011  
5/1/2014Robert GouldCEOSell30,000$21.91$657,300.00  
4/28/2014Robert CopelandEVPSell13,800$20.73$286,074.0024,911  
4/7/2014Jason RhodesCFOSell25,000$20.05$501,250.0034,000  
4/7/2014Robert GouldCEOSell30,000$20.22$606,600.00  
2/10/2014Celgene European Investment Comajor shareholderBuy340,000$29.25$9,945,000.00  
1/6/2014Jason RhodesCFOSell10,000$20.19$201,900.004,000  
12/16/2013Robert CopelandEVPSell4,600$21.21$97,566.0053,544  
12/2/2013Robert CopelandEVPSell5,000$20.70$103,500.0053,544  
11/15/2013M James Barrettmajor shareholderBuy406,500$19.68$7,999,920.00  
6/5/2013David M MottDirectorBuy400,000$15.00$6,000,000.00  
6/5/2013Venture Fund I L.P. AstellasMajor ShareholderBuy15,333$15.00$229,995.00  
(Data available from 1/1/2013 forward)












Epizyme (NASDAQ:EPZM) Insider Trade Frequently Asked Questions

Who is on Epizyme's Insider Roster?

The list of insiders at Epizyme includes Carl Goldfischer, David M Mott, Jeffery Kutok, Joseph Beaulieu, Matthew Ros, Paolo Tombesi, Robert B Bazemore, and Shefali Agarwal.Learn more on EPZM's insiders

What percentage of Epizyme stock is owned by insiders?

17.50% of Epizyme stock is owned by insiders. Learn more on EPZM's insider holdings

Which Epizyme insiders have been buying company stock?

The following insiders have purchased Epizyme stock in the last 24 months: Carl Goldfischer ($60,350.00), and David M Mott ($1,219,447.95).

How much insider buying is happening at Epizyme?

Insiders have purchased a total of 95,250 Epizyme shares in the last 24 months for a total of $1,279,797.95 bought.

Which Epizyme insiders have been selling company stock?

The following insiders have sold Epizyme stock in the last 24 months: Jeffery Kutok ($17,855.20), Joseph Beaulieu ($42,849.86), Matthew Ros ($2,411,713.24), Paolo Tombesi ($59,589.20), Robert B Bazemore ($808,947.45), and Shefali Agarwal ($149,394.49).

How much insider selling is happening at Epizyme?

Insiders have sold a total of 190,634 Epizyme shares in the last 24 months for a total of $3,640,671.53 sold.

This page was last updated on 12/7/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.